Cipher Pharma has a huge upside, says Echelon Wealth

Mar 21 20:03 2019 Print This Article

Look for Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Chart TSX:CPH) to break out of its slump in 2019, says Doug Loe of Echelon Wealth Partners. Loe gives a 12-month return of 257 per cent for the stock, saying the specialty pharma company’s pipeline prospects are encouraging. Cipher Pharmaceuticals released its fourth quarter and fiscal 2018 […]

The post Cipher Pharma has a huge upside, says Echelon Wealth appeared first on Cantech Letter.

Read More

About Article Author

Cantech Letter

Founded in 2008 by Nick Waddell, Cantech Letter is an online magazine focusing on Canadian technology. The site has grown into one of the most popular and respected financial sites in Canada, and was described by Canadian Business Magazine as “one of Canada’s premier technology newsletters”. Waddell, who is Senior Editor, is routinely called on by the mainstream media for perspective on Canadian technology, and has been featured on BNN, CTV News Channel, and the CBC program “The Lang and O’Leary Exchange” in addition to mainstream print media such as The Guardian, The International Business Times, The Globe and Mail, Macleans, The Waterloo Record , Canadian Business, Slate, and Business Insider. You can email Nick at nick@cantechletter.com Cantech Letter is focused on those companies listed on the TSX and TSXV Technology, Cleantech and Life Sciences Sectors. Each year we present the Cantech Letter Awards, which honor Canada’s Top Technology Stock and Top Technology Stock Executive.

Related Items

Valuation of Pharma Companies: 5 Key Considerations

Valuing pharma companies isn’t the same as valuing non-pharma companies, for several reasons. Traditional business considerations are compounded by patent law and FDA approval processes when evaluating the investment potential of… The post Valuation of Pharma Companies: 5 Key Considerations app ...

Truncated Week Ahead: NIFTY Likely To Remain In A Broad Range; Watching These Levels Continues To Remain Imp

In the week that went by, the Indian equity markets did not make any directional move on any side. The index oscillated back and forth in a defined range and went on to end the week on a flat note. The India Volatility Index – INDIAVIX, also remained flat losing just 0.01 points (-0.05%) during t ...

Truncated Week Ahead: NIFTY Likely To Remain In A Broad Range; Watching These Levels Continues To Remain Important

In the week that went by, the Indian equity markets did not make any directional move on any side. The index oscillated back and forth in a defined range and ultimately ended the week on a flat note. The India Volatility Index (INDIAVIX) also remained flat, losing just 0.01 points (-0.05%) during t ...

Merchandise Trade Balance Slips into a Deficit Position in July

Ottawa, September 4, 2019— “With exports falling and imports rising, Canada's merchandise trade balance slipped into a $1.1 billion deficit position in July.” says Doris Chu, a Senior Economist with the Conference Board of Canada.  “After powering the economy in the second quarter, Canada ...

Week Ahead: NIFTY Has A Treacherous Road Ahead; These Sectors To Relatively Out-Perform As Per RRG

The Indian equity markets struggled throughout the previous week to keep its head above the crucial levels and ended the week with modest gains. On anticipated lines, the week remained very volatile as the markets oscillated in a 385-points range. The week that went by digested the reforms initiate ...

Organigram is ready for a breakout, Beacon says

Beacon Securities analyst Russell Stanley continues to be bullish on Organigram Holdings (Organigram Holdings Stock Quote, Chart News TSX:OGI), saying that the Moncton, New Brunswick, cannabis company looks ready for a breakout. On Monday, Organigram reported that it had received Health Canada appr ...

Canopy Growth Corp has never been in better shape, Mark Zekulin says

Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart, News TSX:WEED) may be in search mode for a new CEO at the moment but Mark Zekulin has nothing but praise for his company. There has been a gloomy picture painted by WEED’s share price of late, but the current CEO thinks Canopy is in great ...

Five Canadian pot stocks to buy for triple-digit returns in 2020

Canadian pot stocks. Dead money? The clouds have moved in over the Canadian cannabis space. Lackluster results from presumptive leader Canopy Growth Corp and a full-blown scandal via CannTrust Holdings have combined with a hundred smaller cuts to sink the returns for hot money investors used to wha ...

Biotech penny stock Antibe Therapeutics has a huge upside: Echelon

Echelon Wealth Partners analyst Douglas Loe is holding steady on his investment thesis for clinical stage drug developer Antibe Therapeutics (Antibe Therapeutics Stock Quote, Chart, News TSXV:ATE), maintaining in a client update on Wednesday his “Speculative Buy” recommendation and $1.40 target ...

Raymond James launches coverage of Profound Medical Corp with a $4.00 target

Raymond James analyst Rahul Sarugaser thinks Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News TSX:PRN) is profoundly undervalued. In a research report to clients today, the analyst initiated coverage of the Toronto-based medical device company with an “Outperform” rating an ...